China

What lies ahead for China’s robotic surgical systems market?

What lies ahead for China’s robotic surgical systems market?

Continued investment and increasing regulatory approvals will sustain market growth.
6 days ago

China's ophthalmic laser market eyes 4% CAGR growth until 2033

The country accounted for 25% of the Asia-Pacific market in 2024.

Ping An Health’s net profit hit $21.8m in 2024

The group’s revenue reached $665m (RMB 4.81b) during the period.

Perennial Holdings opens 1,000-bed medical cluster in Tianjin, China

The $275m (RMB 2b) development includes three hospitals.

Aier Eye Hospital Group to face slower revenue growth in 2025-26: report

Weaker demand for services and economic uncertainties pose key challenges.

China’s CRDMO firms gain temporary reprieve with Biosecure act delay

The act’s postponement opens opportunities to expand overseas investment.

China's intraocular lens market to see 2% CAGR until 2033

Its expansion is attributed to the rising prevalence of myopia.

Parkway Shanghai unveils new brand positioning and expansion plans

The group plans to open an ambulatory care centre next year.

What factors drive China’s proton therapy market?

China is expanding its network of centres across major cities.

China’s artificial hip and knee joints market to hit $1.01b by 2030

Thanks to a rising incidence of age-related joint disorders.

Mainland China’s pharmaceutical sales to hit $345b by 2033

Global drugmakers seek partnerships to boost their presence in the world's second-largest pharmaceutical market.

Medical equipment, services sectors to benefit from China’s fiscal boost

The Ministry of Finance may issue $142b of special bonds to stimulate consumption.

China emerges as key player in oncology with antibody-drug conjugates surge

It represents 82% of the ADC pipeline in major APAC markets.

China to allow wholly foreign-owned hospitals in select areas

Conditions, requirements, and procedures for set-up will be specified at a later date.

China's LAA closure devices market to grow at 5% CAGR through 2033

The competitive landscape is expected to fuel an increase in research and development investments.